James Brian Windsor, See Remarks at Rein Therapeutics, Inc. (RNTX), bought 25,000 shares at $1.00 ($25K) on 2026-04-30, disclosed to the SEC on 2026-05-13.
James Brian Windsor purchased 25,000 shares at $1.00, representing the largest insider purchase in Rein Therapeutics' history. This significant buyback suggests the insider sees value despite the stock's recent underperformance.
RNTX is currently trading at $1.15, which is 15% above its 52-week low of $1.00 but down 52.08% from its high of $2.40. The stock has declined 41.33% over the past year.
The largest insider purchase in company history occurred on April 30, 2026, signaling strong conviction from the buyer.
The stock exhibits high volatility with a beta of 1.418, and a short interest of 3.54% poses a risk of continued selling pressure.
Something here stands out, but not much.
| Filing → |
| ALRN | BUY | 2023-11-21 | $10K | — | Filing → |
| TFFP | SELL | 2020-12-09 | $395K | — | Filing → |
| TFFP | BUY | 2019-10-29 | $25K | — | Filing → |